These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 15125987

  • 1. Anxiety sensitivity and modulation of the serotonergic system in patients with PD.
    Romano P, van Beek N, Cucchi M, Biffi S, Perna G.
    J Anxiety Disord; 2004; 18(3):423-31. PubMed ID: 15125987
    [Abstract] [Full Text] [Related]

  • 2. Serotonin, panic disorder and agoraphobia: short-term and long-term efficacy of citalopram in panic disorders.
    Humble M, Wistedt B.
    Int Clin Psychopharmacol; 1992 Jun; 6 Suppl 5():21-39. PubMed ID: 1431019
    [Abstract] [Full Text] [Related]

  • 3. Predictors of symptom resolution in panic disorder after one year of pharmacological treatment: a naturalistic study.
    Marchesi C, Cantoni A, Fontò S, Giannelli MR, Maggini C.
    Pharmacopsychiatry; 2006 Mar; 39(2):60-5. PubMed ID: 16555166
    [Abstract] [Full Text] [Related]

  • 4. [Efficacy and tolerability of escitalopram in anxiety disorders: a review].
    Pelissolo A.
    Encephale; 2008 Sep; 34(4):400-8. PubMed ID: 18922243
    [Abstract] [Full Text] [Related]

  • 5. What is the threshold for symptomatic response and remission for major depressive disorder, panic disorder, social anxiety disorder, and generalized anxiety disorder?
    Bandelow B, Baldwin DS, Dolberg OT, Andersen HF, Stein DJ.
    J Clin Psychiatry; 2006 Sep; 67(9):1428-34. PubMed ID: 17017830
    [Abstract] [Full Text] [Related]

  • 6. Tryptophan depletion does not modify response to CCK-4 challenge in patients with panic disorder after treatment with citalopram.
    Tõru I, Shlik J, Maron E, Vasar V, Nutt DJ.
    Psychopharmacology (Berl); 2006 May; 186(1):107-12. PubMed ID: 16541242
    [Abstract] [Full Text] [Related]

  • 7. Citalopram in the treatment of early-onset panic disorder and school phobia.
    Lepola U, Leinonen E, Koponen H.
    Pharmacopsychiatry; 1996 Jan; 29(1):30-2. PubMed ID: 8852532
    [Abstract] [Full Text] [Related]

  • 8. The 35% CO2 hyperreactivity and clinical symptomatology in patients with panic disorder after 1 week of treatment with citalopram: an open study.
    Bertani A, Caldirola D, Bussi R, Bellodi L, Perna G.
    J Clin Psychopharmacol; 2001 Jun; 21(3):262-7. PubMed ID: 11386488
    [Abstract] [Full Text] [Related]

  • 9. A comparison of citalopram and paroxetine in the treatment of panic disorder: a randomized, single-blind study.
    Perna G, Bertani A, Caldirola D, Smeraldi E, Bellodi L.
    Pharmacopsychiatry; 2001 May; 34(3):85-90. PubMed ID: 11434404
    [Abstract] [Full Text] [Related]

  • 10. The effect of citalopram treatment on platelet serotonin function in panic disorders.
    Neuger J, Wistedt B, Sinner B, Aberg-Wistedt A, Stain-Malmgren R.
    Int Clin Psychopharmacol; 2000 Mar; 15(2):83-91. PubMed ID: 10759339
    [Abstract] [Full Text] [Related]

  • 11. [A new quality of the therapy of anxiety and depression--escitalopram].
    Neznanov NG, Bortsov AV.
    Zh Nevrol Psikhiatr Im S S Korsakova; 2005 Mar; 105(2):79-84. PubMed ID: 15792148
    [No Abstract] [Full Text] [Related]

  • 12. Facing the fear--clinical and neural effects of cognitive behavioural and pharmacotherapy in panic disorder with agoraphobia.
    Liebscher C, Wittmann A, Gechter J, Schlagenhauf F, Lueken U, Plag J, Straube B, Pfleiderer B, Fehm L, Gerlach AL, Kircher T, Fydrich T, Deckert J, Wittchen HU, Heinz A, Arolt V, Ströhle A.
    Eur Neuropsychopharmacol; 2016 Mar; 26(3):431-44. PubMed ID: 26837851
    [Abstract] [Full Text] [Related]

  • 13. Effects of citalopram treatment on behavioural, cardiovascular and neuroendocrine response to cholecystokinin tetrapeptide challenge in patients with panic disorder.
    Shlik J, Aluoja A, Vasar V, Vasar E, Podar T, Bradwejn J.
    J Psychiatry Neurosci; 1997 Nov; 22(5):332-40. PubMed ID: 9401314
    [Abstract] [Full Text] [Related]

  • 14. Improvement of quality of life in panic disorder with escitalopram, citalopram, or placebo.
    Bandelow B, Stein DJ, Dolberg OT, Andersen HF, Baldwin DS.
    Pharmacopsychiatry; 2007 Jul; 40(4):152-6. PubMed ID: 17694478
    [Abstract] [Full Text] [Related]

  • 15. The effect of citalopram in panic disorder.
    Wade AG, Lepola U, Koponen HJ, Pedersen V, Pedersen T.
    Br J Psychiatry; 1997 Jun; 170():549-53. PubMed ID: 9330022
    [Abstract] [Full Text] [Related]

  • 16. Effect of citalopram treatment on relationship between platelet serotonin functions and the Karolinska scales of personality in panic patients.
    Neuger J, Wistedt B, Aberg-Wistedt A, Stain-Malmgren R.
    J Clin Psychopharmacol; 2002 Aug; 22(4):400-5. PubMed ID: 12172340
    [Abstract] [Full Text] [Related]

  • 17. Psychological characteristics of early remitters in patients with panic disorder.
    Park HJ, Kim EJ, Ku JI, Woo JM, Lee SH, Chung SK, Lee SY, Kim YR, Kang EH, Lee JH, Kim JH, Yu BH.
    Psychiatry Res; 2012 May 30; 197(3):237-41. PubMed ID: 22370156
    [Abstract] [Full Text] [Related]

  • 18. Reboxetine and citalopram in panic disorder: a single-blind, cross-over, flexible-dose pilot study.
    Seedat S, van Rheede van Oudtshoorn E, Muller JE, Mohr N, Stein DJ.
    Int Clin Psychopharmacol; 2003 Sep 30; 18(5):279-84. PubMed ID: 12920388
    [Abstract] [Full Text] [Related]

  • 19. Increased brain serotonin turnover in panic disorder patients in the absence of a panic attack: reduction by a selective serotonin reuptake inhibitor.
    Esler M, Lambert E, Alvarenga M, Socratous F, Richards J, Barton D, Pier C, Brenchley C, Dawood T, Hastings J, Guo L, Haikerwal D, Kaye D, Jennings G, Kalff V, Kelly M, Wiesner G, Lambert G.
    Stress; 2007 Aug 30; 10(3):295-304. PubMed ID: 17613943
    [Abstract] [Full Text] [Related]

  • 20. A naturalistic long-term comparison study of selective serotonin reuptake inhibitors in the treatment of panic disorder.
    Dannon PN, Iancu I, Lowengrub K, Gonopolsky Y, Musin E, Grunhaus L, Kotler M.
    Clin Neuropharmacol; 2007 Aug 30; 30(6):326-34. PubMed ID: 18090457
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.